Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Iron is increased in the brains of ageing mice lacking the neurofilament light gene

  • James C. Vickers ,

    Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing

    James.Vickers@utas.edu.au

    Affiliation Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, Australia

  • Anna E. King,

    Roles Conceptualization, Formal analysis, Writing – original draft

    Affiliation Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, Australia

  • Graeme H. McCormack,

    Roles Formal analysis, Investigation, Methodology, Project administration, Writing – original draft

    Affiliation Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, Australia

  • Aidan D. Bindoff,

    Roles Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

    Affiliation Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, Australia

  • Paul A. Adlard

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Validation, Writing – original draft

    Affiliation The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia

Abstract

There has been strong interest in the role of metals in neurodegeneration, and how ageing may predispose the brain to related diseases such as Alzheimer’s disease. Recent work has also highlighted a potential interaction between different metal species and various components of the cytoskeletal network in the brain, which themselves have a reported role in age-related degenerative disease and other neurological disorders. Neurofilaments are one such class of intermediate filament protein that have a demonstrated capacity to bind and utilise cation species. In this study, we investigated the consequences of altering the neurofilamentous network on metal ion homeostasis by examining neurofilament light (NFL) gene knockout mice, relative to wildtype control animals, at adulthood (5 months of age) and advanced age (22 months). Inductively coupled plasma mass spectroscopy demonstrated that the concentrations of iron (Fe), copper (Cu) and zinc (Zn) varied across brain regions and peripheral nerve samples. Zn and Fe showed statistically significant interactions between genotype and age, as well as between genotype and region, and Cu demonstrated a genotype and region interaction. The most substantial difference between genotypes was found in Fe in the older animals, where, across many regions examined, there was elevated Fe in the NFL knockout mice. This data indicates a potential relationship between the neurofilamentous cytoskeleton and the processing and/or storage of Fe through ageing.

Introduction

Divalent cation metal species such as zinc, iron and copper have important normal cellular functions in the nervous system, but may also be involved in pathological processes underlying neurodegenerative diseases such as Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) [13]. Indeed, metal ions have been implicated in many aspects of the AD cascade [4], including a potentially central role in the aggregation of the two primary pathological hallmarks of AD, the beta amyloid plaques and neurofibrillary tangles [5]. In this regard, major proteins implicated in neurodegenerative diseases such as the amyloid precursor protein (APP), tau and alpha-synuclein and tau have been shown to be involved in metal ion processing and transport [68]. Furthermore, metal ions may promote aggregation of these proteins, contributing to hallmark pathological features [9].

A range of brain proteins have the capacity to bind metal species, with major cell groups, such as neurons, microglia and astrocytes likely having a spectrum of roles in terms of the storage, metabolism and use of metals. Neurofilaments (NF) are major neuronal proteins and have putative roles in stabilising axons and regulating axonal diameter [10]. Particular subsets of neurons demonstrate high levels of the NF ‘triplet’ proteins (NF light (NFL), medium (NFM) and heavy (NFH) see [10] for review on subunit structure and function), and these correspond to subpopulations of neurons that are vulnerable to degeneration in AD (cortical pyramidal neurons), PD (substantia nigra compacta) and ALS (cortical, brainstem and spinal motor neurons) [1113]. The NFM and NFH subunits have long tail domains that project from the intermediate filament backbone, and which contain glutamate-rich, negatively charged subregions. In this regard, these protein regions may bind to cations, with accessibility regulated by phosphorylation of the tail domains [14].

Neurofilament accumulation in abnormal (dystrophic) neurites associated with beta amyloid plaques in the cortex is one of the earliest neuronal changes in the sequence of pathological changes leading to AD [13]. The NFL protein is a requisite component for the NF triplet to form intermediate filaments in neurons. We have also recently demonstrated that the ablation of NFL in a transgenic mouse model of AD (APPswe/PS1dE9) results in increased beta amyloid plaque deposition [15]. These data suggest that the absence of NFs may have an early role in amyloid misprocessing. Furthermore, substantia nigra neurons in PD also lose NF content [11], which is associated with the accumulation of iron in these nerve cells [1]. Collectively, these data suggest that NF triplet-abundant neurons may show changes in these cytoskeletal proteins as part of the disease process of major neurodegenerative changes, and that such changes contribute to subsequent pathological alterations potentially with respect to a role in metal biology within neurons. The following study explores the potential consequences of a major perturbation of NFs with metal ions, on the background of ageing. We have utilised mass spectrometry techniques to compare the abundance of metal species implicated in major neurodegenerative diseases, such as iron (Fe), copper (Cu) and zinc (Zn), in the brains and peripheral nerves of NFL KO mice as compared to C57BL/6 mice at adulthood (5 months of age) and following ageing (22 months of age).

Materials and methods

Animals and tissue processing

All animal experimentation was approved by the University of Tasmania Animal Ethics Committee (Approval Nos A12780 and A15120), in accordance with the Australian code of practice for the care and use of animals for scientific purposes. NFL KO mice were obtained from the Nathan Kline Institute (Dr. Mala Rao) and were developed in the laboratory of Dr. Jean-Pierre Julien [16]. NFL KO mice were maintained as a homozygous knockout colony. NFL KO mice (on a C57BL/6 background strain) were compared with wild-type (WT) (C57BL/6) mice, the predominant background strain of the mice [16,17]. Animals were housed in standard conditions (20°C, 12/12 hours light/dark cycle), with at least 2 animals in each cage with access to food and water ad libitum. Cohort sizes were as follows, 5 months (n = 11 NFL-KO, n = 7 WT) and 22 months (n = 6 NFL-KO, n = 7 WT).

Tissue collection and processing

Animals were anaesthetised with 140mg/Kg sodium pentobarbitone (intraperitoneal) and perfused transcardially with phosphate buffered saline for 3 mins to clear blood from the vasculature. Tissue was dissected under microscopic guidance. Briefly, cortical tissue, hippocampus, olfactory bulb and cerebellum were collected from each hemisphere and the right hemisphere used in analysis; brain stem tissue was collected and left and right sciatic nerves were pooled for analysis. Upon collection, tissue was rapidly snap frozen in liquid nitrogen and stored at -80°C until used. Tissue was freeze dried in 96 well plates for 48hrs at -80°C. Dried tissue was kept at room temperature until used.

Inductively coupled plasma mass spectroscopy (ICPMS) analysis

Tissue samples were coded and processed for inductively coupled mass spectroscopy analysis at the Florey Institute of Neuroscience and Mental Health. Tissue samples were lyophilised and then digested with nitric acid (65% Suprapur, Merck) overnight, followed by heating at 90°C for 20 min using a heat block. Samples were then removed from the heat block and an equivalent volume of hydrogen peroxide (30% Aristar, BDH) added to each sample. Once samples had finished digesting, they were heated for a further 15 mins at 70°C. Samples were then diluted with 1% nitric acid diluent. Measurements were made using an Agilent 7700 series ICPMS instrument under routine multi-element operating conditions using a Helium Reaction Gas Cell. The instrument was calibrated using 0, 5, 10, 50, 100 and 500 ppb of certified multi-element ICPMS standard calibration solutions (ICP-MS-CAL2-1, ICP-MS-CAL-3 and ICP-MS-CAL-4, Accustandard) for a range of elements, and we also utilised a certified internal standard solution containing 200 ppb of Yttrium (Y89) as a control (ICP-MS-IS-MIX1-1, Accustandard).

Statistical analysis

Mixed effects models were fitted using the lme4 package in R. Random intercepts for each subject were specified in order to account for non-independence between brain regions within animals. Model assumptions were checked using standard graphical techniques, and a loge-transformation applied to Zn and Fe variables to improve normality of residuals and homogeneity of error variance. One substantial outlier was removed from Cu. Type III F statistics and 95% Confidence Intervals for the estimated marginal means were computed using the Kenward-Roger approximation for degrees of freedom. A measure of standardized effect size, Cohen’s f2 was calculated for the effect of genotype for each metal using the formula, where is the coefficient of determination for the full model, and is the coefficient of determination for a reduced model that does not contain the term of interest. The method of Nakagawa and Schielzeth [18] for computing a marginal pseudo-R2 for mixed models was used to calculate R2 coefficients.

Results and discussion

Broadly, Fe content was increased in NFL KO and WT mice with ageing across most nervous system samples, with the exception of the olfactory bulb. In this regard, there was a more substantial ageing-related increase in Fe content in NFL KO mice relative WT animals, particularly in the cerebellum, cortex, hippocampus and sciatic nerve (Fig 1). For many CNS regions, there was higher content of Zn in older NFL KO mice relative to WT mice. In addition, the sciatic nerve of NFL KO mice showed higher levels of Zn that WT mice at both 5 and 22 months of age. No consistent pattern of difference between NFL KO and WT mice was observed for Cu.

thumbnail
Fig 1. Metal composition at different ages.

Fe, Zn, and Cu in sampled brain regions at 5mo and 22mo, for WT and NFL-KO mice. Error-bars show estimated marginal means (over all regions) and 95% CI, showing the strength and direction of these patterns of metal accumulation. There were significant genotype x age interactions for Zn and Fe (Zn: F(1, 27) = 9, p = .005; Fe: F(1, 27) = 11, p = .002).

https://doi.org/10.1371/journal.pone.0224169.g001

Genotype x age (Fig 1) and genotype x region (Fig 2) interactions were investigated for each metal cation in a model which accounted for region x age interactions and intra-class correlation within region for each animal. For Zn and Fe, there were significant genotype x age interactions (Zn: F(1, 27) = 9, p = .005; Fe: F(1, 27) = 11, p = .002) and genotype x region interactions (Zn: F(5, 140) = 8, p < .001; Fe: F(5, 140) = 3, p = .021). For Cu, only the genotype x region interaction was significant (F(5, 139) = 4, p = .002).

thumbnail
Fig 2. Metal variability in different brain regions.

Estimated marginal means (and 95% CI) show patterns of Fe, Zn, and Cu composition in different brain regions for the two genotypes (WT and NFL-KO; averaged over 5mo and 22mo animals). There were significant genotype x region interactions for Zn, Fe and Cu (Zn: F(5, 140) = 8, p < .001; Fe: F(5, 140) = 3, p = .021; F(5, 139) = 4, p = .002).

https://doi.org/10.1371/journal.pone.0224169.g002

The standardized effect of genotype on Cu accumulation in tissues was small (), however the standardized effect of genotype on Zn and Fe accumulation in tissues was moderate ().

The current study shows that there were differences in Cu, Zn and Fe concentrations across regions of the nervous system. For example, Fe was relatively abundant in the brain stem, with lower levels in the olfactory bulb. The olfactory bulb also showed relatively lower levels of both Zn and Cu. The sciatic nerve demonstrated very low levels of Cu, relative to Fe and Zn.

One of the most prominent differences between NFL KO and WT mice was found for Fe, especially for older animals. Moderate genotype differences were also detected for Zn, with the most pronounced difference was present for sciatic nerve. In many regions, Zn abundance did not decrease in the NFL KO mice over ageing relative to the WT mice. Consistent patterns of genotype difference for Cu were not observed.

These studies were motivated by our previous observations that APPswe/PS1dE9 mice on a NFL KO background demonstrated higher amyloid plaque deposition [15]. In this regard, we were interested in potential differences in brain content of Fe, Zn and Cu, metals implicated in beta amyloid processing and aggregation into plaques, that may be related to the absence of NFL and a complete neurofilamentous network [16,17]. The relatively increased levels of Fe across most brain regions of aged NFL KO mice, as well as relatively maintained levels of Zn, may be particularly significant in the context of contributing to an environment that drives Alzheimer’s disease pathology. We have previously shown that there are substantial changes in NF localisation in the hippocampus during ageing, that abnormal accumulation of NFs in dystrophic neurites surrounding plaques is the earliest neuronal pathology of AD and that tau pathology replaces the normal NF network in neurofibrillary tangles and dystrophic neurites [13]. Changes to the integrity of neurofilamentous networks during ageing could possibly also follow decades of wear and tear on axons, and may possibly result in increased levels of Fe in the extracellular environment, which then impact on multiple aspects of AD pathogenesis. The translation of APP, which is the parent protein to the Abeta of extracellular plaques in the AD brain, is regulated by an iron response element in the APP mRNA [19,20] and the secretase cleavage of APP to form Abeta is also regulated by iron. Furthermore, the aggregation and oligomerization of Abeta is potentiated by iron, which is also likely to contribute to Abeta-mediated oxidative damage [2126]. Similarly, iron can induce the aggregation of tau [27] and the association of redox active iron with tau and neurofibrillary tangles may contribute to oxidative stress [28]. In addition, a loss of NFs in substantia nigra neurons in the early stages of PD [11] may also be linked to the accumulation of Fe in these cells [1].

The current data supports the existence of a relationship between NF protein levels and metal ions in the brain, potentially relating to the regulation and/or storage of metals. Cations may also have direct roles in the organisation of neurofilamentous networks. Iron deficiency, for example, can impact neurofilament phosphorylation during development [29]. Copper and iron may also have a role in catechol-mediated cross-linking of neurofilament proteins [30], and copper and zinc have the capacity to directly bind to the NFH subunit [31]. Divalent ions such as Ca, Mg and Zn have been shown to act as cross-linkers between NFs, influencing the gelation and viscoelastic properties of neurofilamentous networks [32,33]. Finally, atomic force microscopy experiments support the cross-linking role of divalent cations, particularly in moderating the spacing and mechanical properties of phosphorylated NF side-arm structures [34].

Conclusions

Cumulatively, these data show that the absence of NF-L, and a neurofilamentous network perturbs the processing and/or storage of Fe through ageing, leading to higher levels of this metal in the brain and sciatic nerve. Biomarker studies indicate a progressive perturbation of NFs with ageing and neuroaxonal degeneration involving these proteins across a wide range of neurodegenerative conditions [35]. Hence, alterations in neurofilaments during brain ageing may, thus, create an intracellular or extracellular environment of excess Fe, which could contribute to risk of either neuronal degeneration or protein accumulation in neurodegenerative conditions such as Alzheimer’s and/or Parkinson’s disease.

Acknowledgments

This work was funded by the J.O. and J.R. Wicking Trust (Equity Trustees). The Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant.

References

  1. 1. Belaidi AA, Bush AI. Iron neurochemistry in Alzheimer’s disease and Parkinson’s disease: targets for therapeutics. J Neurochem. 2016; 139:179–219.
  2. 2. Portbury AD, Adlard PA. Zinc signal in brain diseases. Int J Mol Sci. 2017; 18, E2506. pmid:29168792
  3. 3. Giampietro R, Spinelli F, Contino M, Colabufo NA. The pivotal role of copper in neurodegeneration: A new strategy for the therapy of neurodegenerative disorders. Mol Pharm. 2018; 15, 808–820. pmid:29323501
  4. 4. Adlard PA, Bush AI. (2006) Metals and Alzheimer’s disease. J Alzheimers Dis. 2006; 10: 145–163. pmid:17119284
  5. 5. Cristóvão JS, Santos R, Gomes CM. Metals and neuronal metal binding proteins implicated in Alzheimer’s disease. Oxid Med Cell Longev. 2016; 2016: 9812178. pmid:26881049
  6. 6. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer’s disease. Cell. 2010; 142: 857–867. pmid:20817278
  7. 7. Lei P, Ayton S, Appukuttan AT, Moon S, Duce JA, Volitakis I, et al. Lithium suppression of tau induces brain iron accumulation and neurodegeneration. Mol Psychiatry. 2017;22: 396–406. pmid:27400857
  8. 8. Joppe K, Roser A-E, Maass F, Lingor P. The contribution of iron to protein aggregation disorders in the central nervous system. Frontiers Neurosci. 2019; 13: 15.10.
  9. 9. Ortega R, Carmona A, Roudeau S, Perrin L, Ducic T, Carboni E, et al. Alpha-Synuclein over-expression induces increased iron accumulation and redistribution in iron-exposed neurons. Mol Neurobiol. 2016; 53: 1925–1934. pmid:25833099
  10. 10. Kirkcaldie MTK, Dwyer ST. The third wave: Intermediate filaments in the maturing nervous system. Mol Cell Neurosci. 2017; 84: 68–76. pmid:28554564
  11. 11. Gai WP, Vickers JC, Blumbergs PC, Blessing WW. Loss of non-phosphorylated neurofilament immunoreactivity with preservation of tyrosine hydroxylase in surviving substantia nigra neurons in Parkinson’s disease. J Neurol Neurosurg Psychiat. 1994; 57: 1039–1046. pmid:7916375
  12. 12. Vickers JC, King AE, Woodhouse A, Kirkcaldie MT, Staal JA, McCormack GH et al. Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system. Brain Res Bull. 2009; 80: 217–223. pmid:19683034
  13. 13. Vickers JC, Kirkcaldie MTK, Phipps AJ, King AE. Alterations in neurofilaments and the transformation of the cytoskeleton in axons may provide insight into the aberrant neuronal changes of Alzheimer’s disease. Brain Res Bull. 2016; 126: 324–333. pmid:27475416
  14. 14. Lefebvre S, Mushynski ME. Characterization of the cation-binding properties of porcine neurofilaments. Biochemistry. 1988; 27: 8503–8508. pmid:3149507
  15. 15. Fernandez-Martos CM, King AE, Atkinson RA, Woodhouse A, Vickers JC. Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer’s disease. Neurobiol Aging. 2015; 36: 2757–2767. pmid:26344875
  16. 16. Zhu Q, Couillard-Després S, Julien JP. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol. 1997; 148: 299–316. pmid:9398473
  17. 17. Liu Y, Staal JA, Canty AJ, Kirkcaldie M, King AE, Bibari O. et al. Cytoskeletal changes during development and aging in the cortex of neurofilament light protein knockout mice. J Comp Neurol. 2013; 521: 1817–1827. pmid:23172043
  18. 18. Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed‐effects models. Methods Ecol Evolution. 2013; 4: 133–142.
  19. 19. Rogers JT, Leiter LM, McPhee J, Cahill CM, Zhan , Potter H et al. Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5’-untranslated region sequences. J Biol Chem. 1999; 274: 6421–6431. pmid:10037734
  20. 20. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H et al. An iron-responsive element type II in the 5’-untranslated region of the Alzheimer’s amyloid precursor protein transcript. J Biol Chem. 2002; 277: 45518–45528. pmid:12198135
  21. 21. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR et al. Cu(II) potentiation of alzheimer Abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem. 1999; 274: 37111–37116. pmid:10601271
  22. 22. Huang X, Atwood CS, Moir RD, Hartshorn MA, Tanzi RE, Bush AI. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Abeta peptides. J Biol Inorg Chem. 2004; 9: 954–960. pmid:15578276
  23. 23. Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC et al. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem. 2011; 286: 4248–4256.
  24. 24. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER et al. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem. 1993; 61: 1171–1174. pmid:8360682
  25. 25. Schubert D, Chevion M. The role of iron in beta amyloid toxicity. Biochem Biophys Res Commun. 1995; 216: 702–707. pmid:7488167
  26. 26. Jomova K, Vondrakova D, Lawson M, Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010; 345: 91–104. pmid:20730621
  27. 27. Yamamoto A, Shin RA, Hasegawa K, Naiki H, Sato H, Yoshimasu F et al. Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer’s disease. J Neurochem. 2002; 82: 1137–1147. pmid:12358761
  28. 28. Good PF, Perl DP, Bierer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer’s disease: a laser microprobe (LAMMA) study. Ann Neurol. 1992; 31: 286–292. pmid:1637136
  29. 29. Lee DL, Strathmann FG, Gelein R, Walton J, Mayer-Pröschel M. Iron deficiency disrupts axon maturation of the developing auditory nerve. J Neurosci. 2012; 32: 5010–5015. pmid:22492056
  30. 30. Montine TJ, Farris DB, Graham DG. Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J Neuropathol Exp Neurol. 1995; 54: 311–319. pmid:7745430
  31. 31. Pierson KB, Evenson MA. 200 Kd neurofilament protein binds Al, Cu and Zn. Biochem Biophys Res Commun. 1988; 152: 598–604. pmid:3130052
  32. 32. Yao NY, Broedersz CP, Lin YC, Kasza KE, Mackintosh FC, Weitz DA. Elasticity in ionically cross-linked neurofilament networks. Biophys J. 2010; 98: 2147–2153. pmid:20483322
  33. 33. Pregent S, Lichtenstein A, Avinery R, Laser-Azogui A, Patolsky F, Beck R. Probing the interactions of intrinsically disordered proteins using nanoparticle tags. Nano Lett. 2015; 15: 3080–3087. pmid:25822629
  34. 34. Lei R, Lee JP, Francis MB, Kumar S. Structural regulation of a neurofilament-inspired intrinsically disordered protein brush by multisite phosphorylation. Biochemistry. 2018; 57: 4019–4028. pmid:29557644
  35. 35. Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol. 2019 pmid:31206160